Bolt Biotherapeutics Ratios (2019-2025) | BOLT

Ratios Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -5,264.02%-16,505.97%-3,111.04%-5,345.87%-2,912.42%-1,626.99%-1,030.26%-1,417.22%-929.90%-1,260.08%-643.08%-857.01%-293.63%-1,662.35%-1,330.06%-905.24%-477.33%-333.15%
EBIT Margin -5,332.32%-16,582.09%-3,128.46%-5,329.72%-2,936.78%-1,655.35%-1,058.05%-1,491.14%-1,008.49%-1,383.95%-719.26%-946.19%-324.08%-1,772.31%-1,441.10%-991.41%-510.53%-355.14%
EBITDA Margin -5,270.12%-16,489.55%-3,113.03%-5,401.57%-3,044.65%-1,656.21%-1,025.80%-1,361.23%-892.44%-1,259.67%-640.90%-846.91%-206.37%-1,662.98%-1,308.24%-908.10%-477.11%-329.55%
Operating Margin -5,332.32%-16,582.09%-3,128.46%-5,329.72%-2,936.78%-1,655.35%-1,058.05%-1,491.14%-1,008.49%-1,383.95%-719.26%-946.19%-324.08%-1,772.31%-1,441.10%-991.41%-510.53%-355.14%
Net Margin -5,264.02%-16,505.97%-3,111.04%-5,345.87%-2,912.42%-1,626.99%-1,030.26%-1,417.22%-929.90%-1,260.08%-643.08%-857.01%-293.63%-1,662.35%-1,330.06%-905.24%-477.33%-333.15%
FCF Margin -6,104.27%-19,559.70%-2,625.27%-3,613.39%-3,065.07%-1,523.04%-671.69%-1,285.33%-1,283.95%-1,054.57%-668.63%-683.15%-317.61%-1,268.94%-1,224.36%-1,093.70%-531.98%-452.01%
Efficiency
Assets Average 185.59M335.86M340.31M320.63M295.26M271.51M252.87M236.66M216.99M198.44M183.03M167.57M151.34M133.53M116.75M104.48M92.75M80.68M70.28M
Equity Average -59.63M-69.81M-89.77M99.15M299.57M285.40M262.52M239.26M218.18M198.21M179.98M164.60M149.91M135.20M120.50M108.45M95.01M78.95M64.61M52.00M42.83M35.47M
Invested Capital -54.23M-65.04M-74.59M-104.95M303.25M295.90M274.91M250.12M228.39M207.97M188.45M171.51M157.69M142.13M128.26M112.74M104.16M85.86M72.03M57.20M46.81M38.84M32.10M
Asset Utilization Ratio 0.000.000.000.010.010.020.020.030.030.040.050.070.080.080.070.040.050.07
Leverage & Solvency
Equity Ratio -2.250.930.850.820.810.810.800.770.750.760.750.730.710.730.690.660.570.550.510.49
Valuation
Enterprise Value -34.83M-11.61M-45.31M-17.79M-22.84M-266.67M-244.99M-212.89M-186.22M-190.90M-176.34M-171.13M-168.89M-126.38M-125.87M-119.72M-102.19M-91.35M-73.70M-53.80M-47.32M-88.45M-73.67M-52.96M
Return Ratios
Return on Sales -52.64%-165.06%-138.84%-212.05%-602.24%-31.11%-53.46%-29.12%-16.27%-10.30%-14.17%-9.30%-12.60%-6.43%-8.57%-2.94%-16.62%-13.30%-8.82%-9.05%-4.77%-3.33%
Return on Capital Employed -0.20%-0.24%-0.30%-0.36%-0.39%-0.42%-0.42%-0.42%-0.45%-0.47%-0.52%-0.56%-0.67%-0.77%-0.82%-0.86%-0.80%-0.76%
Return on Assets -0.22%-0.16%-0.19%-0.23%-0.33%-0.36%-0.38%-0.37%-0.38%-0.39%-0.39%-0.41%-0.45%-0.53%-0.60%-0.65%-0.68%-0.63%-0.61%
Return on Equity 0.46%0.55%-0.41%-0.18%-0.22%-0.28%-0.41%-0.44%-0.48%-0.49%-0.49%-0.51%-0.53%-0.57%-0.62%-0.75%-0.88%-1.05%-1.22%-1.19%-1.21%